1JHUND P S,MACINTYRE K,SIMPSON C R,et al.Long-term trends in first hospitalization for heart failure and subsequent survival between 1986-2003:a population study of 5.1 milion people[J].Circulation,2009,119:515-523. 被引量：1
2TRIPOSKIADIS F,KARAYANNIS G,GIAMOUZIS G,et al.The sympathetic nercous system in heart failure:physiology,pathophysiology,and clinical implications[J].JACC,2009,54:1747-1762. 被引量：1
3KATARE R G,ANDO M,KAKINUMA Y,et al.Vagal stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of the bradycardiac effect[J].J Thorac Cardiovasc Surg,2008,137:223-231. 被引量：1
4OLSHANSKY B,NSABBAH H,JHAUPYMAN P,et al.Parasympathetic nervous system and heart failure[J].Circulation,2008,118:863-871. 被引量：1
5KAKINUMA Y,AKIYAMA T,AND SATO T.Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium[J].FEBS J,2009,276:5111-5125. 被引量：1
6ZHANG Y,POPOVIC Z B,BIBEVSKI S,et al.Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model[J].Circ Heart Fail,2009,2:692-699. 被引量：1
7SCHWARTZ P J,DE FERRARI G M,SANZO A,et al.Long term vagal stimulation in patients with advanced heart failure:first experience in man[J].Eur J Heart Fail,2008,10:884-891. 被引量：1
8DE FERRARI G M,SANZO A,SCHWARTZ P J.Chronic vagal stimulation in patients with congestive heart failure[J].Conf Proc IEEE Eng Med Biol Soc,2009,2009:2037-2039. 被引量：1
9SATO K,URBANO R,YU C,et al.Protective effect of donepezil on cardiovascular mortality[J].Circulation,2008,117:e269. 被引量：1
10HANDA T G,KATARE R,KAKINUMA Y,et al.Anti-Alzheimer's drug,donepezil,markedly improves long-term survival after chronic heart failure in mice[J].J Cardiac Fail,2009,15:805-811. 被引量：1
